A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR)

The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin prevent transfusions among chemotherapy-associated anemia patients. Clinical trials, meta-analyses, and guidelines identify mortality, tumor progression, and venous thromboembolism (VTE) risks with ESA administration in this...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bennett, Charles L., Spiegel, David M., Macdougall, Iain C., Norris, LeAnn, Qureshi, Zaina P., Sartor, Oliver, Lai, Stephen Y., Tallman, Martin S., Raisch, Dennis W., Smith, Sheila Weiss, Silver, Samuel, Murday, Alanna S., Armitage, James O., Goldsmith, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947540/
https://ncbi.nlm.nih.gov/pubmed/23111861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0032-1328884
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi